However, the pro-lymphangiogenic effects of these proteins seem to be tumor-specific, as THBS1 and PEDF may dampen tumor lymphangiogenesis in colorectal [69] and prostate cancers [70]. This evidence concerns the gene THBS1 and neoplasm.